background
tuberculosi
tb
one
world
major
communic
infecti
diseas
still
impos
great
health
burden
develop
countri
develop
drugresist
tb
treatment
increas
treatment
complex
longterm
pulmonari
complic
complet
treatment
rais
epidem
health
burden
studi
intend
investig
util
chines
medicin
cm
respiratori
symptom
patient
medic
histori
tb
taiwan
method
analyz
cohort
one
million
individu
randomli
select
nation
health
insur
research
databas
taiwan
inclus
criteria
patient
n
histori
tb
code
tb
diagnos
januari
decemb
year
old
clinic
record
least
month
complet
demograph
inform
record
treatment
firstlin
tb
medic
prescript
cm
user
condit
respiratori
discomfort
n
exclud
final
total
tb
patient
categor
cm
user
respiratori
discomfort
n
noncm
user
n
result
among
subject
cm
user
noncm
user
femal
patient
younger
yo
live
urban
area
rel
tend
cm
user
p
cm
user
receiv
chines
medicin
commonli
prescrib
herbal
formula
singl
herb
xiaoqinglongtang
radix
platycodoni
jiegeng
respect
core
pattern
chines
medicin
tb
patient
consist
maxingganshitang
bulbu
fritillaria
thunbergii
beimu
radix
platycodoni
jiegeng
semen
armeniaca
xingren
conclus
use
cm
popular
among
patient
medic
histori
tb
complic
longterm
respiratori
discomfort
taiwan
pharmacolog
investig
clinic
trial
requir
twentyfirst
centuri
tuberculosi
tb
continu
one
world
major
health
challeng
tb
deadli
communic
diseas
primarili
transmit
human
human
droplet
infect
major
health
burden
develop
develop
countri
approxim
million
peopl
develop
tb
million
die
diseas
million
estim
case
southeast
asian
western
pacif
region
china
account
million
estim
tb
case
tb
case
confirm
taiwan
male
elderli
immunocompromis
patient
includ
hiv
patient
poorli
control
diabet
mellitu
chronic
kidney
diseas
receiv
immunosuppress
treatment
gener
suscept
diseas
healthcar
worker
expos
tb
also
higher
risk
infect
due
side
effect
drug
poor
medic
complianc
problem
develop
drugresist
tb
global
invest
tb
research
need
among
firstlin
antitb
drug
side
effect
hepatotox
report
associ
isoniazid
rifampin
pyrazinamid
cutan
reaction
isoniazid
pyrazinamid
ethambutol
gastrointestin
intoler
rifampin
retrobulbar
neuriti
ethambutol
ototox
streptomycin
longterm
respiratori
symptom
impair
pulmonari
function
affect
patient
qualiti
life
complet
tb
treatment
respiratori
comorbid
identifi
half
microbiolog
cure
tb
patient
despit
success
treatment
tb
residu
impair
persist
chronic
complic
sequela
aris
structur
vascular
alter
diseas
site
mani
patient
chronic
ill
may
seek
complementari
therapi
especi
chines
medicin
cm
asian
countri
cm
origin
ancient
china
defin
comprehens
healthcar
skill
practic
mainten
health
treatment
diseas
base
belief
holism
experi
pattern
identif
syndrom
differenti
hand
gener
gener
taiwan
cm
import
popular
among
differ
categori
complementari
therapi
regard
one
mainstream
therapi
coverag
nation
health
insur
nhi
program
cm
usual
refer
overal
treatment
modal
servic
cm
cover
nhi
program
includ
chines
medicin
acupunctur
moxibust
chines
traumatolog
therapi
chines
medicin
usual
refer
herb
herbal
product
classifi
singleherb
product
herbal
formula
multiherb
product
taiwan
herbal
product
concentr
scientif
herbal
granul
cover
nhi
program
manufactur
gmpcertifi
pharmaceut
compani
ancient
cm
literatur
use
word
tb
rather
consid
pulmonari
condit
relat
syndrom
lung
consumpt
character
cough
hemoptysi
tidal
fever
night
sweat
emaci
due
consumpt
exhaust
overstrain
report
chines
medicin
combin
convent
medicin
benefici
effect
inhibit
mycobacterium
strengthen
immun
system
bodi
enhanc
effect
antitb
drug
reduc
drug
resist
rel
safe
sever
studi
investig
use
cm
care
tb
patient
lack
kind
survey
use
cm
among
patient
medic
histori
tb
complic
longterm
respiratori
discomfort
intend
investig
util
cm
among
patient
medic
histori
tb
complic
longterm
respiratori
discomfort
studi
result
studi
use
futur
clinic
trial
pharmacolog
investig
regard
efficaci
safeti
nhi
program
establish
taiwan
program
highli
repres
sampl
taiwan
gener
popul
reimburs
polici
univers
mandatori
coverag
rate
compulsori
health
insur
program
reach
almost
end
taiwan
cm
servic
reimburs
nhi
program
includ
chines
medicin
acupunctur
moxibust
chines
traumatolog
therapi
nation
health
insur
administr
provid
registr
file
origin
claim
data
nation
health
research
institut
establish
manag
nation
health
insur
research
databas
nhird
research
purpos
studi
base
part
data
nhird
contain
data
compris
demograph
characterist
medic
care
facil
outpati
inpati
visit
visit
date
diagnost
code
manag
prescript
medic
expenditur
acquir
randomli
select
sampl
consist
one
million
individu
longitudin
health
insur
databas
lhid
nhird
manag
releas
nation
health
research
institut
taiwan
diagnost
code
intern
classif
diseas
ninth
revis
clinic
modif
format
studi
follow
ethic
standard
respons
committe
helsinki
declar
later
version
dataset
deidentifi
encrypt
releas
nation
health
research
institut
taiwan
individu
care
provid
could
identifi
databas
patient
consent
exempt
total
anonym
research
data
studi
therefor
research
ethic
committe
china
medic
univers
hospit
approv
studi
waiv
requir
inform
consent
patient
newli
diagnos
tb
code
n
select
databas
avoid
inclus
patient
diseas
set
inclus
criteria
allow
patient
newli
diagnos
tb
januari
decemb
clinic
record
least
month
treatment
firstlin
tb
medic
prescript
isoniazid
rifampin
pyrazinamid
ethambutol
n
preval
etiolog
tb
infect
children
differ
medic
servicesseek
behavior
among
children
adolesc
mainli
domin
parent
children
tb
infect
includ
object
therefor
exclud
patient
less
year
age
miss
inform
relat
birth
sex
n
total
tb
patient
includ
therefor
sampl
inclus
criteria
follow
tb
diagnos
januari
decemb
year
old
clinic
record
least
month
complet
demograph
inform
record
treatment
firstlin
tb
medic
prescript
cm
user
defin
visit
cm
clinic
cm
outpati
clinic
record
tb
respiratori
diseas
code
noncm
user
defin
never
visit
cm
clinic
initi
diagnosi
tb
investig
tb
patient
complic
longterm
respiratori
discomfort
exclud
clinic
visit
nontb
respiratori
diagnosi
n
final
total
tb
patient
categor
cm
user
n
noncm
user
n
fig
taiwan
countri
popul
million
taiwan
geograph
area
km
citi
township
taiwan
mani
resid
live
within
urban
citi
residenti
area
citi
taiwan
classifi
level
urban
base
popul
densiti
peoplekm
ratio
popul
vari
educ
level
number
physician
per
peopl
level
repres
highest
urban
level
repres
lowest
level
level
urban
defin
urban
area
level
classifi
rural
area
list
herbal
formula
phonet
pinyin
name
singl
herb
phonet
pinyin
name
chines
materi
medica
name
plant
name
indic
herbal
formula
singl
herb
base
cm
theori
full
botan
name
accord
intern
plant
name
list
ipni
http
wwwipniorg
plant
list
http
wwwtheplantlistorg
opensourc
freewar
node
xl
http
nodexlcodeplexcom
util
identifi
core
pattern
prescript
tb
patient
common
coprescrib
chines
medicin
demonstr
network
analysi
previous
describ
larger
spot
thickerlin
width
indic
signific
prescript
pattern
count
close
connect
formula
herb
network
figur
statist
analys
perform
use
sa
softwar
version
sa
institut
inc
cari
nc
usa
univari
analysi
util
compar
cm
user
noncm
user
data
analysi
compris
descript
statist
includ
frequenc
herbal
prescript
patient
demograph
characterist
indic
tcm
prescript
frequent
prescrib
herbal
formula
herb
treat
tb
chisquar
test
use
examin
relationship
categor
variabl
examin
differ
cm
user
noncm
user
pvalu
consid
statist
signific
studi
identifi
n
patient
medic
histori
tb
visit
cm
clinic
cm
outpati
clinic
record
tb
respiratori
diseas
fig
femal
younger
yo
live
higher
urban
area
level
rel
like
use
cm
median
durat
newli
diagnos
tb
first
cm
consult
day
tabl
regard
treatment
mode
employ
among
cm
user
approxim
cm
user
n
receiv
chines
medicin
patient
receiv
combin
treatment
chines
medicin
acupunctur
remain
patient
receiv
acupunctur
treatment
among
cm
user
patient
medic
histori
tb
visit
cm
clinic
cm
outpati
clinic
record
tb
respiratori
diseas
n
visit
cm
clinic
time
annual
patient
consult
cm
doctor
timesyear
tabl
frequenc
distribut
diseas
categori
relat
respiratori
discomfort
comorbid
patient
diagnos
tb
analyz
tabl
compar
noncm
user
frequenc
outpati
visit
among
tb
patient
use
cm
statist
higher
across
almost
discomfort
comorbid
except
swell
mass
lump
chest
tabl
tb
patient
use
cm
acut
respiratori
infect
cough
chronic
obstruct
pulmonari
diseas
alli
condit
diseas
upper
respiratori
tract
result
could
indic
comorbid
complic
tb
may
serv
explan
tb
patient
complic
longterm
respiratori
discomfort
turn
cm
doctor
help
tabl
investig
prescript
pattern
chines
medicin
identifi
ten
commonli
prescrib
formula
singl
herb
ten
commonli
prescrib
singl
herb
herbal
formula
analyz
list
tabl
respect
commonli
prescrib
herbal
formula
singl
herb
xiaoqinglongtang
radix
platycodoni
jiegeng
respect
conduct
network
analysi
found
core
pattern
herbal
formula
herb
prescrib
tb
patient
consist
maxingganshitang
bulbu
fritillaria
thunbergii
beimu
radix
platycodoni
jiegeng
semen
armeniaca
xingren
fig
summar
find
fig
studi
first
observ
median
durat
newli
diagnos
tb
first
cm
consult
day
mani
tb
patient
complic
longterm
respiratori
discomfort
sought
cm
servic
determin
maxingganshitang
bulbu
fritillaria
thunbergii
beimu
radix
platycodoni
jiegeng
semen
armeniaca
xingren
core
prescript
patient
tb
taiwan
best
knowledg
report
describ
first
nationwid
populationbas
cohort
studi
investig
cm
util
pattern
among
tb
patient
complic
longterm
respiratori
discomfort
howev
whether
cm
combin
modern
convent
medicin
benefici
effect
risk
requir
investig
phenomenon
femal
patient
tb
rel
like
seek
cm
servic
compar
previou
taiwanes
survey
demonstr
women
greater
tendenc
seek
cm
consult
report
women
suscept
side
effect
antitb
drug
due
higher
activ
although
men
suscept
tb
women
women
may
exhibit
helpseek
behavior
men
like
seek
complementari
therapi
suffer
chronic
catastroph
ill
also
observ
younger
patient
yo
live
urban
area
rel
like
choos
cm
accord
previou
studi
patient
younger
year
old
like
awar
altern
therapeut
choic
previou
report
shown
women
peopl
high
socioeconom
statu
higher
educ
level
selfperceiv
poor
health
statu
peopl
exercis
regularli
tend
visit
cm
servic
often
taiwan
patient
resid
urban
area
usual
higher
socioeconom
statu
fewer
barrier
access
medic
servic
time
money
spent
transport
may
also
lead
signific
inequ
contact
health
system
therefor
peopl
live
urban
area
greater
tendenc
use
cm
servic
taiwan
patient
diagnosi
tb
requir
receiv
pharmacolog
therapi
control
tb
infect
monitor
local
health
offic
base
govern
health
polici
includ
patient
diagnos
tb
receiv
standard
antitb
treatment
taiwan
recommend
standard
treatment
adult
respiratori
tb
consist
regimen
isoniazid
rifampicin
pyrazinamid
ethambutol
month
follow
isoniazid
rifampicin
ethambutol
month
monitor
local
health
offic
accord
government
polici
total
treatment
cours
take
approxim
month
newli
diagnos
patient
median
durat
newli
diagnos
tb
first
cm
consult
day
followup
period
patient
might
seek
cm
consult
due
symptom
respiratori
discomfort
complic
addit
respiratori
ill
may
also
experi
symptom
relat
antitb
treatment
skin
rash
drug
fever
gi
intoler
nausea
vomit
visual
toxic
hear
disturb
arthralgia
nhi
insur
coverag
cm
treatment
may
play
consider
role
patient
tendenc
seek
cm
consult
medic
servic
western
medicin
cm
promot
due
high
coverag
nhi
program
furthermor
cost
copay
concentr
scientif
herbal
granul
approxim
us
dollar
per
month
nhi
program
taiwan
tendenc
patient
seek
cm
may
continu
increas
sinc
copay
chines
medicin
rel
low
among
patient
tb
cm
user
receiv
chines
medicin
consist
previou
studi
investig
respiratori
diseas
herbal
product
frequent
use
treatment
cm
visit
taiwan
patient
adultonset
asthma
patient
visit
cm
physician
receiv
chines
medicin
cmtreat
rhinosinus
subject
prescrib
chines
medicin
regard
diseas
categori
cm
user
identifi
tabl
tb
patient
use
cm
acut
respiratori
infect
cough
chronic
obstruct
pulmonari
diseas
alli
condit
diseas
upper
respiratori
tract
report
complic
tb
includ
bacteri
pneumonia
cor
pulmonal
pneumothorax
acut
respiratori
failur
complic
tb
could
result
progress
function
pulmonari
impair
structur
lung
destruct
patient
prior
tb
diagnosi
twice
like
lung
airflow
obstruct
furthermor
complic
respiratori
diseas
independ
predictor
shorter
surviv
among
patient
tb
tb
patient
might
also
turn
cm
doctor
hope
reliev
symptom
improv
health
must
note
tb
appear
diseas
name
record
chine
medic
literatur
howev
ancient
peopl
observ
diseas
symptom
sign
tb
relat
ill
record
discuss
chines
medic
literatur
prescript
cm
accord
concept
tb
cm
relat
chronic
cough
symptom
sign
consumpt
exhaust
prescript
prescrib
pattern
identif
syndrom
differenti
base
theori
cm
prescript
list
tabl
help
reliev
symptom
caus
yin
qi
defici
lung
wind
contract
correspond
respiratori
symptom
relat
longterm
respiratori
discomfort
among
singl
herb
identifi
core
prescript
herb
bulbu
fritillaria
thunbergii
commonli
use
antituss
agent
isosteroid
alkaloid
report
tracheobronchi
relax
activ
radix
platycodoni
use
bronchiti
tonsil
laryng
ancient
time
pharmacolog
constitu
platycodin
radix
platycodoni
demonstr
antiinflammatori
antitumor
antinocicept
immunomodulatori
activ
immunostimulatori
effect
reveal
via
suppress
content
enhanc
kill
activ
natur
killer
cell
radix
platycodoni
also
inhibit
ovainduc
airway
inflamm
regul
product
secret
airway
mucin
furthermor
radix
platycodoni
often
serv
expector
divers
inflammatori
pulmonari
diseas
herb
core
prescript
semen
armeniaca
antiinflammatori
analges
effect
suppress
product
amygdalin
found
use
antituss
antiasthmat
anticanc
agent
addit
three
herb
herb
report
reliev
respiratori
symptom
reduc
inflamm
herba
houttuynia
yuxingcao
report
reliev
fever
cough
asthma
antiinflammatori
antivir
activ
herb
inhibit
product
proinflammatori
cytokin
via
inhibit
signal
pathway
human
mast
cell
semen
trichosanthi
gualouren
antiinflammatori
antibacteri
activ
immunomodulatori
effect
ophiopogonind
radix
ophiopogoni
maimendong
may
benefici
reduc
excit
parasympathet
ganglion
neuron
airway
cholinerg
control
airway
function
antituss
effect
might
due
activ
k
channel
hyperpolar
paratrach
neuron
radix
salvia
miltiorrhiza
danshen
could
help
reduc
lung
fibrosi
speci
report
exhibit
antiinflammatori
antioxid
effect
radix
scutellaria
huangqin
shown
fig
commonli
prescrib
herbal
formula
singl
herb
patient
tuberculosi
assess
core
pattern
prescript
show
maxingganshitang
beimu
jiegeng
xingren
among
frequent
prescrib
combin
pharmacolog
effect
antiinflammatori
antitumor
hepatoprotect
addit
extract
antioxid
antibacteri
antivir
effect
research
indic
decoct
contain
fructu
schisandra
wuweizi
help
prevent
alveol
develop
pulmonari
fibrosi
liverprotect
effect
fructu
schisandra
via
inhibitori
effect
activ
report
may
also
amelior
side
effect
hepat
result
use
antitb
medic
among
herbal
formula
identifi
research
maxingganshitang
one
core
prescript
use
treat
asthma
fever
associ
pneumonia
possess
antiasthmat
antipyret
antiinflammatori
antituss
effect
xiaoqinglongtang
antiinflammatori
antivir
antiallergi
activ
reduc
inflamm
lung
tissu
via
antiapoptot
effect
inhibit
cytokin
releas
well
prevent
pulmonari
fibrosi
dingchuantang
shown
antiasthmat
effect
clinic
studi
protect
effect
lung
injuri
asthma
occur
suppress
product
proinflammatori
cytokin
significantli
reduc
inflammatori
cell
infiltr
goblet
cell
prolifer
collagen
deposit
damag
bronchi
alveoli
xinyiqingfeitang
commonli
use
rhiniti
shown
reduc
eosinophil
serum
ige
level
clinic
studi
report
yiqiaosan
may
help
patient
influenza
reduc
durat
fever
lung
cancer
patient
display
better
physic
function
role
function
cumul
surviv
receiv
combin
treatment
formula
contain
baihegu
jintang
western
medicin
limit
studi
first
herbal
product
purchas
patient
expens
addit
nhi
program
product
includ
studi
howev
copay
herbal
product
nhi
program
much
less
market
cost
possibl
purchas
herb
outsid
nhi
program
rel
low
addit
complianc
prescript
regimen
difficult
measur
final
studi
focus
util
cm
patient
tb
futur
highqual
random
control
clinic
trial
imag
data
speci
cultur
determin
efficaci
chines
medicin
tb
expect
studi
found
mani
tb
patient
complic
longterm
respiratori
discomfort
sought
cm
servic
taiwan
yo
femal
live
urban
area
tend
use
cm
prescript
pattern
identifi
studi
could
use
futur
clinic
studi
pharmacolog
investig
avail
data
materi
dataset
analyz
nhird
provid
nation
health
insur
administr
maintain
nation
health
research
institut
taiwan
use
nhird
limit
research
purpos
applic
must
follow
computerprocess
person
data
protect
law
http
wwwwinklerpartnerscom
relat
regul
nation
health
insur
administr
nation
health
research
institut
author
contribut
sti
conceptu
studi
jhc
perform
statist
analysi
sti
yrl
myw
psi
hri
contribut
interpret
tcm
data
pharmacolog
mechan
tch
contribut
interpret
western
medicin
data
sti
yrl
hri
draft
manuscript
sti
hri
final
manuscript
author
read
approv
final
manuscript
ethic
approv
consent
particip
studi
follow
ethic
standard
respons
committe
helsinki
declar
later
version
dataset
deidentifi
encrypt
releas
nation
health
research
institut
taiwan
individu
care
provid
could
identifi
databas
patient
consent
exempt
total
anonym
research
data
studi
therefor
research
ethic
committe
china
medic
univers
hospit
approv
studi
waiv
requir
inform
consent
applic
